Blacklisting of Onifam Laboratories Ltd

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public notice blacklisting Onifam Laboratories Ltd and associated persons/entities from pharmaceutical business activities in Nigeria. The action is based on investigations that revealed regulatory misrepresentation, improper use of approvals/certificates, and activities compromising product traceability, accountability, and public health. These acts are alleged to be in violation of the NAFDAC Act, Cap. N1 LFN 2004.

The recent public notice issued by NAFDAC has significant implications for pharmaceutical businesses operating in Nigeria. The agency's actions demonstrate its commitment to ensuring compliance with regulatory requirements and protecting public health. This development is particularly noteworthy given the importance of maintaining a robust regulatory framework in the pharmaceutical sector.

NAFDAC, as the primary regulatory body for food and drug administration in Nigeria, has a critical role in ensuring that pharmaceutical products meet safety and efficacy standards. The NAFDAC Act, Cap. N1 LFN 2004, provides the statutory framework for the agency's operations, including powers to investigate and take enforcement action against companies found to be non-compliant with regulations.

The blacklisting of Onifam Laboratories Ltd and associated persons/entities raises several questions about the regulatory environment in Nigeria. Firstly, it highlights the need for pharmaceutical businesses to ensure that they are compliant with all relevant regulations, including those related to product approvals and certifications. Secondly, it underscores the importance of effective enforcement mechanisms to deter non-compliance and protect public health.

The recent public notice issued by NAFDAC serves as a reminder to pharmaceutical businesses operating in Nigeria of the need for strict compliance with regulatory requirements. Practitioners are advised to review their clients' operations to ensure that they meet all relevant standards, including those related to product traceability and accountability.